Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C17H18N2S2 |
| Molecular Weight | 314.468 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
S=C1SCN(CC2=CC=CC=C2)CN1CC3=CC=CC=C3
InChI
InChIKey=QFVAWNPSRQWSDU-UHFFFAOYSA-N
InChI=1S/C17H18N2S2/c20-17-19(12-16-9-5-2-6-10-16)13-18(14-21-17)11-15-7-3-1-4-8-15/h1-10H,11-14H2
| Molecular Formula | C17H18N2S2 |
| Molecular Weight | 314.468 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/17915644
Sources: http://www.ncbi.nlm.nih.gov/pubmed/17915644
Sulbentine has a broad spectrum effect and is used especially in dermatomycoses treatment in the treatment of various forms.
Approval Year
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3214073
Unknown
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 08:29:50 GMT 2025
by
admin
on
Wed Apr 02 08:29:50 GMT 2025
|
| Record UNII |
D0NR12WK9J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QD01AE09
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
||
|
NCI_THESAURUS |
C514
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
||
|
WHO-ATC |
D01AE09
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
67686
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
SUB10678MIG
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
100000083257
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
DB13671
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
SULBENTINE
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
206-497-2
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
m10294
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | Merck Index | ||
|
150555
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
CHEMBL151803
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
D0NR12WK9J
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
DTXSID7046257
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
C72964
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
2379
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
3557
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY | |||
|
350-12-9
Created by
admin on Wed Apr 02 08:29:50 GMT 2025 , Edited by admin on Wed Apr 02 08:29:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |